The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles
Open accessAbstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a β-coronavirus, is the causative agent of the COVID-19 pandemic. Like for other coronaviruses, its particles are composed of four structural proteins, namely Spike S, Envelope E, Membrane M and Nucleoprotein N proteins. The involvement of each of these proteins and their interplays during the assembly process of this new virus are poorly-defined and are likely β-coronavirus-type different. Therefore, we sought to investigate how SARS-CoV-2 behaves for its assembly by expression assays of S, in combination with E, M and/or N. By combining biochemical and imaging assays, we showed that E and M regulate intracellular trafficking of S and hence its furin-mediated processing. Indeed, our imaging data revealed that S remains at ERGIC or Golgi compartments upon expression of E or M, like for SARS-CoV-2 infected cells. By studying a mutant of S, we showed that its cytoplasmic tail, and more specifically, its C-terminal retrieval motif, is required for the M-mediated retention in the ERGIC, whereas E induces S retention by modulating the cell secretory pathway. We also highlighted that E and M induce a specific maturation of S N-glycosylation, which is observed on particles and lysates from infected cells independently of its mechanisms of intracellular retention. Finally, we showed that both M, E and N are required for optimal production of virus-like-proteins. Altogether, our results indicated that E and M proteins influence the properties of S proteins to promote assembly of viral particles. Our results therefore highlight both similarities and dissimilarities in these events, as compared to other β-coronaviruses. Author Summary The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the COVID-19 pandemic. Its viral particles are composed of four structural proteins, namely Spike S, Envelope E, Membrane M and Nucleoprotein N proteins, though their involvement in the virion assembly remain unknown for this particular coronavirus. Here we showed that presence of E and M influence the localization and maturation of S protein, in term of cleavage and N-glycosylation maturation. Indeed, E protein is able to slow down the cell secretory pathway whereas M-induced retention of S requires the retrieval motif in S C-terminus. We also highlighted that E and M might regulate the N glycosylation maturation of S independently of its intracellular retention mechanism. Finally, we showed that the four structural proteins are required for optimal formation of virus-like particles, highlighting the involvement of N, E and M in assembly of infectious particles. Altogether, our results highlight both similarities and dissimilarities in these events, as compared to other β-coronaviruses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ou, X., Liu, Y., Lei, X., Li, P., Mi, D., Ren, L., Guo, L., Guo, R., Chen, T., Hu, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15562-9 · Cited by 3,097
Coronavirus envelope protein: current knowledge
Schoeman, D., & Fielding, B. C. (2019) · Virology Journal · doi:10.1186/s12985-019-1182-0 · Cited by 2,074
The Molecular Biology of Coronaviruses
Masters, P. S. (2006) · Advances in Virus Research · doi:10.1016/s0065-3527(06)66005-3 · Cited by 1,761
Coutard, B., Valle, C., de Lamballerie, X., Canard, B., Seidah, N. G., & Decroly, E. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104742 · Cited by 1,679
Site-specific glycan analysis of the SARS-CoV-2 spike
Watanabe, Y., Allen, J. D., Wrapp, D., McLellan, J. S., & Crispin, M. (2020) · Science · doi:10.1126/science.abb9983 · Cited by 1,548
Furin at the cutting edge: From protein traffic to embryogenesis and disease
Thomas, G. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm934 · Cited by 1,216
Blond, J.-L., Lavillette, D., Cheynet, V., Bouton, O., Oriol, G., Chapel-Fernandes, S., Mandrand, B., Mallet, F., & Cosset, F.-L. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3321-3329.2000 · Cited by 716
Self-citationNieto-Torres, J. L., DeDiego, M. L., Verdiá-Báguena, C., Jimenez-Guardeño, J. M., Regla-Nava, J. A., Fernandez-Delgado, R., Castaño-Rodriguez, C., Alcaraz, A., Torres, J., Aguilella, V. M., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004077 · Cited by 559
Nieto-Torres, J. L., Verdiá-Báguena, C., Jimenez-Guardeño, J. M., Regla-Nava, J. A., Castaño-Rodriguez, C., Fernandez-Delgado, R., Torres, J., Aguilella, V. M., & Enjuanes, L. (2015) · Virology · doi:10.1016/j.virol.2015.08.010 · Cited by 511
Siu, Y. L., Teoh, K. T., Lo, J., Chan, C. M., Kien, F., Escriou, N., Tsao, S. W., Nicholls, J. M., Altmeyer, R., Peiris, J. S. M., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01052-08 · Cited by 501
Molecular Interactions in the Assembly of Coronaviruses
de Haan, C. A. M., & Rottier, P. J. M. (2005) · Advances in Virus Research · doi:10.1016/s0065-3527(05)64006-7 · Cited by 408
The intracellular sites of early replication and budding of SARS-coronavirus
Stertz, S., Reichelt, M., Spiegel, M., Kuri, T., Martínez-Sobrido, L., García-Sastre, A., Weber, F., & Kochs, G. (2007) · Virology · doi:10.1016/j.virol.2006.11.027 · Cited by 382
Krijnse-Locker, J., Ericsson, M., Rottier, P., & Griffiths, G. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.1.55 · Cited by 340
Coronavirus M proteins accumulate in the Golgi complex beyond the site of virion budding
Klumperman, J., Locker, J. K., Meijer, A., Horzinek, M. C., Geuze, H. J., & Rottier, P. J. (1994) · Journal of Virology · doi:10.1128/jvi.68.10.6523-6534.1994 · Cited by 314
SARS coronavirus E protein forms cation-selective ion channels
Wilson, L., Mckinlay, C., Gage, P., & Ewart, G. (2004) · Virology · doi:10.1016/j.virol.2004.09.033 · Cited by 293
Nal, B., Chan, C., Kien, F., Siu, L., Tse, J., Chu, K., Kam, J., Staropoli, I., Crescenzo-Chaigne, B., Escriou, N., et al. (2005) · Journal of General Virology · doi:10.1099/vir.0.80671-0 · Cited by 272
Structure and Inhibition of the SARS Coronavirus Envelope Protein Ion Channel
Pervushin, K., Tan, E., Parthasarathy, K., Lin, X., Jiang, F. L., Yu, D., Vararattanavech, A., Soong, T. W., Liu, D. X., & Torres, J. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000511 · Cited by 253
Translational reprogramming in cellular stress response
Liu, B., & Qian, S. (2014) · WIREs RNA · doi:10.1002/wrna.1212 · Cited by 253
Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia
Pizzorno, A., Padey, B., Julien, T., Trouillet-Assant, S., Traversier, A., Errazuriz-Cerda, E., Fouret, J., Dubois, J., Gaymard, A., Lescure, F.-X., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100059 · Cited by 252
Coronavirus E protein forms ion channels with functionally and structurally-involved membrane lipids
Verdiá-Báguena, C., Nieto-Torres, J. L., Alcaraz, A., DeDiego, M. L., Torres, J., Aguilella, V. M., & Enjuanes, L. (2012) · Virology · doi:10.1016/j.virol.2012.07.005 · Cited by 217
Fischer, F., Stegen, C. F., Masters, P. S., & Samsonoff, W. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.7885-7894.1998 · Cited by 211
Coronavirus envelope (E) protein remains at the site of assembly
Venkatagopalan, P., Daskalova, S. M., Lopez, L. A., Dolezal, K. A., & Hogue, B. G. (2015) · Virology · doi:10.1016/j.virol.2015.02.005 · Cited by 210
LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus
Gramberg, T., Hofmann, H., Möller, P., Lalor, P. F., Marzi, A., Geier, M., Krumbiegel, M., Winkler, T., Kirchhoff, F., Adams, D. H., et al. (2005) · Virology · doi:10.1016/j.virol.2005.06.026 · Cited by 203
Hsieh, P.-K., Chang, S. C., Huang, C.-C., Lee, T.-T., Hsiao, C.-W., Kou, Y.-H., Chen, I.-Y., Chang, C.-K., Huang, T.-H., & Chang, M.-F. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.13848-13855.2005 · Cited by 200
More than one door – Budding of enveloped viruses through cellular membranes
Welsch, S., Müller, B., & Kräusslich, H.-G. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.03.060 · Cited by 196
Characterization of the Coronavirus Mouse Hepatitis Virus Strain A59 Small Membrane Protein E
Raamsman, M. J. B., Locker, J. K., de Hooge, A., de Vries, A. A. F., Griffiths, G., Vennema, H., & Rottier, P. J. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.5.2333-2342.2000 · Cited by 196
Sakaguchi, T., Leser, G. P., & Lamb, R. A. (1996) · The Journal of cell biology · doi:10.1083/jcb.133.4.733 · Cited by 191
McBride, C. E., Li, J., & Machamer, C. E. (2007) · Journal of Virology · doi:10.1128/jvi.02146-06 · Cited by 182
Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System
Xu, R., Shi, M., Li, J., Song, P., & Li, N. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00862 · Cited by 178
Coronavirus virulence genes with main focus on SARS-CoV envelope gene
DeDiego, M. L., Nieto-Torres, J. L., Jimenez-Guardeño, J. M., Regla-Nava, J. A., Castaño-Rodriguez, C., Fernandez-Delgado, R., Usera, F., & Enjuanes, L. (2014) · Virus Research · doi:10.1016/j.virusres.2014.07.024 · Cited by 177
Yang, Y., Xiong, Z., Zhang, S., Yan, Y., Nguyen, J., Ng, B., Lu, H., Brendese, J., Yang, F., Wang, H., et al. (2005) · Biochemical Journal · doi:10.1042/bj20050698 · Cited by 162
Incorporation of Spike and Membrane Glycoproteins into Coronavirus Virions
Ujike, M., & Taguchi, F. (2015) · Viruses · doi:10.3390/v7041700 · Cited by 156
Surjit, M., Boping, L. I. U., Jameel, S., Chow, V. T. K., & Lal, S. K. (2004) · Biochemical Journal · doi:10.1042/bj20040984 · Cited by 151
The cytoplasmic tails of infectious bronchitis virus E and M proteins mediate their interaction
Corse, E., & Machamer, C. E. (2003) · Virology · doi:10.1016/s0042-6822(03)00175-2 · Cited by 149
The Missing Link in Coronavirus Assembly
Lim, K. P., & Liu, D. X. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009731200 · Cited by 147
Retroviral Vectors Pseudotyped with Severe Acute Respiratory Syndrome Coronavirus S Protein
Giroglou, T., Cinatl, J. J., Rabenau, H. F., Drosten, C., Schwalbe, H., Doerr, H. W., & von Laer, D. (2004) · Journal of Virology · doi:10.1128/jvi.78.17.9007-9015.2004 · Cited by 145
Huang, Y., Yang, Z., Kong, W., & Nabel, G. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12557-12565.2004 · Cited by 132
An, S., Chen, C., Yu, X., Leibowitz, J. L., & Makino, S. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7853-7859.1999 · Cited by 122
Konan, K. V., Giddings, T. H., Ikeda, M., Li, K., Lemon, S. M., & Kirkegaard, K. (2003) · Journal of Virology · doi:10.1128/jvi.77.14.7843-7855.2003 · Cited by 108
Ruch, T. R., & Machamer, C. E. (2010) · Journal of Virology · doi:10.1128/jvi.01570-10 · Cited by 107
Robbins, S. G., Frana, M. F., McGowan, J. J., Boyle, J. F., & Holmest, K. V. (1986) · Virology · doi:10.1016/0042-6822(86)90305-3 · Cited by 83
Sui, J., Aird, D. R., Tamin, A., Murakami, A., Yan, M., Yammanuru, A., Jing, H., Kan, B., Liu, X., Zhu, Q. K., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000197 · Cited by 82
Fung, T. S., Torres, J., & Liu, D. X. (2015) · Viruses · doi:10.3390/v7062749 · Cited by 75
Glycosylation disorders of membrane trafficking
Rosnoblet, C., Péanne, R., Legrand, D., & Foulquier, F. (2012) · Glycoconjugate Journal · doi:10.1007/s10719-012-9389-y · Cited by 69
Ruch, T. R., & Machamer, C. E. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002674 · Cited by 65
Cited by
Structure of SARS-CoV-2 M protein in lipid nanodiscs
Dolan, K. A., Dutta, M., Kern, D. M., Kotecha, A., Voth, G. A., & Brohawn, S. G. (2022) · eLife · doi:10.7554/elife.81702 · Cited by 82
Metadata
- Authors
- Boson, B., Legros, V., Zhou, B., Siret, E., Mathieu, C., Cosset, F.-L., Lavillette, D., & Denolly, S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 296
- Pages
- 100111
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W3106737244
- Cited by
- 317
- References
- 45
- FWCI
- 5.85
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.